125 related articles for article (PubMed ID: 6187317)
1. Effect of steroids and adenine-arabinoside (araA) on growth and HBsAg production of a human hepatoma cell line.
Clementi M; Bagnarelli P; Pauri P
Arch Virol; 1983; 75(1-2):137-41. PubMed ID: 6187317
[No Abstract] [Full Text] [Related]
2. Effects of suramin on in vitro HBsAg production by PLC/PRF/5 cells and hepatitis B virus DNA polymerase activity.
Kessler HA; Pottage JC; Trenholme GM; Benson CA; Levin S
AIDS Res; 1986 Feb; 2(1):63-72. PubMed ID: 2424468
[TBL] [Abstract][Full Text] [Related]
3. Acute delta hepatitis during treatment with adenosine arabinoside monophosphate with resolution of the HBsAg carrier state.
Garcia G; Smedile A; Bergmann KF; Gerin JL; Gregory PB; Merigan TC; Robinson WS
West J Med; 1990 Jul; 153(1):80-2. PubMed ID: 1697132
[No Abstract] [Full Text] [Related]
4. Inhibition of in vitro HBsAg production by amphotericin B and ketoconazole.
Pottage JC; Kessler HA
J Med Virol; 1985 Jul; 16(3):275-81. PubMed ID: 2993497
[TBL] [Abstract][Full Text] [Related]
5. Toxic neuropathy after adenine arabinoside treatment in chronic HBsAg-positive liver disease.
Kanterewicz E; Bruguera M; Viola C; Lamarca J; Rodés J
J Clin Gastroenterol; 1990 Feb; 12(1):90-2. PubMed ID: 1689332
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of alpha, beta and gamma human interferons on a HBsAg-producing human hepatoma cell line.
Manzin A; Bagnarelli P; Brugia M; Pauri P; Clementi M
Ric Clin Lab; 1986; 16(3):457-62. PubMed ID: 2433727
[TBL] [Abstract][Full Text] [Related]
7. A serum-free growth of a human hepatoma cell line as a tool for hepatocarcinogenesis and virus gene expression.
Bagnarelli P; Brugia M; Clementi M
Dev Biol Stand; 1985; 60():45-53. PubMed ID: 2995177
[TBL] [Abstract][Full Text] [Related]
8. Distribution of hepatitis B surface and core antigens in human liver cell carcinoma and surrounding nontumorous liver.
Hirohashi S; Shimosato Y; Ino Y; Kishi K
J Natl Cancer Inst; 1982 Sep; 69(3):565-8. PubMed ID: 6287080
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen produced by a human hepatoma cell line.
MacNab GM; Alexander JJ; Lecatsas G; Bey EM; Urbanowicz JM
Br J Cancer; 1976 Nov; 34(5):509-15. PubMed ID: 187208
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5'-monophosphate (ARA-AMP).
Weller IV; Bassendine MF; Craxi A; Fowler MJ; Monjardino J; Thomas HC; Sherlock S
Gut; 1982 Sep; 23(9):717-23. PubMed ID: 6179819
[TBL] [Abstract][Full Text] [Related]
11. HBV-DNA in sera of patients with HBsAg-positive primary liver cell carcinoma.
Theilmann L; Gmelin K; Will H; Czygan P; Hasche G; Doerr HW; Kommerell B
Z Gastroenterol; 1984 Apr; 22(4):182-7. PubMed ID: 6328781
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of salvage pathway enzymes by adenine arabinoside 5'-monophosphate (ara-AMP).
Becher HJ; Schollmeyer P
Klin Wochenschr; 1983 Aug; 61(15):751-7. PubMed ID: 6194338
[TBL] [Abstract][Full Text] [Related]
14. Selective inhibition of Ectromelia virus DNA synthesis in hepatocytes by adenine-9-beta-D-arabinofuranoside (ara-A) and adenine-9-beta-D-arabinofuranoside 5'-monophosphate (ara-AMP) conjugated to asialofetuin.
Fiume L; Mattioli A; Busi C; Balboni PG; Barbanti-Brodano G; De Vries J; Altmann R; Wieland T
FEBS Lett; 1980 Jul; 116(2):185-8. PubMed ID: 6157565
[No Abstract] [Full Text] [Related]
15. [An epidemiological study on relationship between hepatitis B virus and hepatocellular carcinoma].
Fukao A
Nihon Shokakibyo Gakkai Zasshi; 1985 Feb; 82(2):232-8. PubMed ID: 2987577
[No Abstract] [Full Text] [Related]
16. Radioimmunometric assay for hepatitis B surface antigen on the surface of infected cells.
Fukusato T; Thung SN; Gerber MA
J Immunol Methods; 1984 Dec; 75(2):325-32. PubMed ID: 6097612
[TBL] [Abstract][Full Text] [Related]
17. [The relation of hepatitis B virus to chronic hepatitis, cirrhosis and primary hepatocellar carcinoma--a study of 367 cases of liver biopsy with orcein staining].
Tang YH
Zhonghua Nei Ke Za Zhi; 1983 Jan; 22(1):17-20, 62-3. PubMed ID: 6188585
[No Abstract] [Full Text] [Related]
18. Inhibition of hepatitis B virus replication by adenine arabinoside monophosphate coupled to lactosaminated albumin. Efficacy and minimal active dose.
Torrani Cerenzia MR; Fiume L; Busi C; Mattioli A; Di Stefano G; Gervasi GB; Brunetto MR; Piantino P; Verme G; Bonino F
J Hepatol; 1994 Feb; 20(2):307-9. PubMed ID: 7516363
[No Abstract] [Full Text] [Related]
19. [Comparative study of the humoral markers associated with hepatitis B virus in hepatocellular carcinoma patients and in subjects with chronic hepatopathy].
de Franchis R; Primignani M; Vecchi M; Zannier PM; Colombo M; Colucci G; Antoniozzi F; Tommasini M
Ann Sclavo; 1982; 24(1):37-48. PubMed ID: 6303232
[No Abstract] [Full Text] [Related]
20. Inhibition of hepatitis B virus replication by vidarabine monophosphate conjugated with lactosaminated serum albumin.
Fiume L; Cerenzia MR; Bonino F; Busi C; Mattioli A; Brunetto MR; Chiaberge E; Verme G
Lancet; 1988 Jul; 2(8601):13-5. PubMed ID: 2455204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
